Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Island Pharmaceuticals has received an $865,230 refund under Australia’s R&D Tax Incentive, which has allowed them to repay a loan from Radium Capital. This funding comes as the company advances its clinical programs, including the promising ISLA-101 nearing a Phase 2a data readout, and explores new assets like galidesivir.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.